A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety, Tolerability of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia.
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 02 Dec 2008 New trial record.